A Bioequivalence Trial of Irbesartan Tablets（0.15g） in Healthy Chinese Subjects

Clinical trial NCT05297929 · UNKNOWN

Trial details

NCT number: NCT05297929
Sponsor: The Affiliated Hospital of Qingdao University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Irbesartan Tablets (0.15g/Tablet)Under Fasted Condition Under Fed Condition Bioequivalence

Start date: 2022-02-17
Primary completion: 2022-04-09
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.